Herzog, T., Hays, J., Moore, K., Konstantinopoulos, P., Gilbert, L., Monk, B., O'Malley, D., Barlin, J., Rege, J., Desai, M., Du, Y., Dalal, R., Coleman, R. L., & Sehouli, J. (n.d.). tP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. International journal of gynecological cancer, 32, A235. http://access.bl.uk/ark:/81055/vdc_100170500844.0x000032